Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis.OBJECTIVE
 Patients were randomized to certolizumab pegol (CZP) or placebo. 
certolizumab pegol
Here we report the incidence of uveitis flares in axial SpA patients from the RAPID-axSpA trial, including ankylosing spondylitis (AS) and nonradiographic (nr) axial SpA.



RAPID-axSpA trial